Profitelligence Profitelligence · Filing Ledger Open BDX research →

Form 8-K · Current Report · Filed 2025-05-02

Becton, Dickinson and Company Updates Corporate Governance By-laws

On April 29, 2025, Becton, Dickinson and Company amended its By-laws to update procedural and disclosure requirements for shareholder meetings, including revisions to Rule 14a-19.

Filer
Becton, Dickinson and Company BDX · NYSE
Filed
Accession
0000010795-25-000041
CIK
0000010795
Signal
Medium impactHealthcare

Details

The amended By-laws were filed as Exhibit 3 to this report.

Items reported

Item 5.03

Amendments to Articles of Incorporation or Bylaws

Bylaw Amendment
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$133.29

Next session

-1.5%

Since filing

+24.3%

Latest close

$165.62

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from BDX reporting the same item, with the next session's move:

Exhibits (1)

About Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another BDX filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts